MAR 29, 2022 8:00 AM PDT

Nasal Spray Shows Promise Against All Variants of SARS-CoV-2

WRITTEN BY: Annie Lennon

A compound delivered via a nasal spray can prevent and treat various SARS-CoV-2 variants in mice. The corresponding study was published in Nature.

COVID-19 vaccines are becoming less effective against SARS-CoV-2 as it continues to mutate. Research is thus underway to develop host-directed therapeutics to limit viral resistance and treat those who contract the virus. 

Recently, researchers at the University of Sherbrooke designed a compound to tackle COVID-19 via nasal spray. Known as N-0385, it targets an enzyme present in nasal cells, where the virus tends to enter and begin infecting human cells. 

"The compound is unique because it blocks entry at the cell surface, without having to get into the cell, which prevents it from causing any detectable cell damage. As well, it's highly potent, in that it needs only a tiny amount to work very effectively," said co-author Dr. Andrea Olmstead, Research Associate in the department of microbiology and immunology at the University of British Columbia. 

In previous work, the researchers tested the compound on four SARS-CoV-2 variants, including Delta, in human lung cells and organoids. They found that it both inhibits infection and does not cause toxicity. 

Researchers at Cornell University then tested the compound in genetically-engineered mice infected with SARS-CoV-2. The ten mice who received daily doses of the compound for four days survived COVID-19 infection, compared to just 20% of untreated mice. 

The researchers then conducted further tests focusing on the Delta variant. In doing so ,they found that N-0385 was not only able to help prevent COVID-19, but also treat the virus 12 hours after infection, as noted by differing levels of the virus in the lungs of treated and untreated mice. 

The researchers say that the compound’s enzyme target has undergone no mutations among the COVID-19 variants, meaning it may remain useful in targeting future strains. Already in unpublished work, they have found that the compound can also block Omnicron variant infections in human lung cells. 

The researchers now hope to test their findings in clinical trials. However, as N-0385 is just an inhibitor- stopping the virus from entering cells- the researchers say it should be used with other drugs already on the market that can reduce replication. 

"The big picture is, there are multiple steps in the life cycle of a virus," said Francois Jean Ph.D., senior author of the paper and Associate Professor in the department of microbiology and immunology at the University of British Columbia. 

"The first step is entering a cell to pass on genetic material, then it goes on to replicate. So you would use both drugs: N-0385 could block most of the virus' entry, making less work for the replicator drug," he added. 

 

Sources: NatureScience Daily

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 21, 2022
Drug Discovery & Development
Antidepressants and Anti-epileptics During Pregnancy May Affect Infant Brain Development
APR 21, 2022
Antidepressants and Anti-epileptics During Pregnancy May Affect Infant Brain Development
Fetal exposure to a mother's antiepileptic or antidepressant medication may affect infant brain development. The cor ...
MAY 17, 2022
Cancer
Looking for an Easier Way to Scale-up Your Benchtop Cell Cultures?
MAY 17, 2022
Looking for an Easier Way to Scale-up Your Benchtop Cell Cultures?
Much has been written about scaling up cell culture for bioprocessing and other applications that require a very high de ...
JUN 06, 2022
Immunology
Using Antibodies to Create Potent Cancer Treatments
JUN 06, 2022
Using Antibodies to Create Potent Cancer Treatments
Cancer can arise from a variety of aberrations that cause cells to divide uncontrollably, and form a tumor. The causes o ...
JUN 10, 2022
Cannabis Sciences
Are Cannabis Users Nicer?
JUN 10, 2022
Are Cannabis Users Nicer?
A study published in Nature offers evidence that cannabis has a positive effect on the psychosocial health of young adul ...
JUN 24, 2022
Cannabis Sciences
Decrease in Youth Substance Use During the Pandemic
JUN 24, 2022
Decrease in Youth Substance Use During the Pandemic
A review published in Child and Family Disaster Psychiatry found that youth substance use declined during the COVID-19 p ...
JUN 26, 2022
Drug Discovery & Development
Acupuncture Alleviates Chronic Tension Headaches in Randomized Controlled Trial
JUN 26, 2022
Acupuncture Alleviates Chronic Tension Headaches in Randomized Controlled Trial
Results from a randomized controlled trial suggest that acupuncture may relieve symptoms of chronic tension-type headach ...
Loading Comments...